Episode 140: Shawn Gremminger on the Hidden Costs of the 340B Drug Pricing Program

In this episode of Listening In (With Permission), Shawn Gremminger, President and CEO of the National Alliance of Healthcare Purchaser Coalitions, joins Andréa Caballero of Catalyst for Payment Reform to dive into a pressing but often overlooked issue: the impact of the 340B Drug Pricing Program on pharmacy costs for employers and healthcare purchasers. The 340B program, originally intended to support safety-net hospitals and community health centers, has expanded drastically over the years. Today, it's the second-largest drug purchasing program in the U.S., with an explosive $65 billion price tag. But what does this mean for employers and employees in the commercial market?

You can listen to Episode 140: Shawn Gremminger on the Hidden Costs of the 340B Drug Pricing Program online on Radio and Podcast. Open the player on this page to stream the available audio.

Episode 140: Shawn Gremminger on the Hidden Costs of the 340B Drug Pricing Program is an episode from Listening In (With Permission): Conversations About Today's Pressing Health Care Topics by Listening In (with Permission...).

This episode is 00:28:33 long.

This episode was published on May 20, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Listening In (With Permission): Conversations About Today's Pressing Health Care Topics when more episodes are available from the podcast feed.